{"id":"https://openalex.org/W4416570902","doi":"https://doi.org/10.1080/17568919.2025.2592533","title":"Design, synthesis, and cytotoxic evaluation of new thiosemicarbazone/thiazolidin-4-one derivatives on PC3 cells","display_name":"Design, synthesis, and cytotoxic evaluation of new thiosemicarbazone/thiazolidin-4-one derivatives on PC3 cells","publication_year":2025,"publication_date":"2025-11-24","ids":{"openalex":"https://openalex.org/W4416570902","doi":"https://doi.org/10.1080/17568919.2025.2592533","pmid":"https://pubmed.ncbi.nlm.nih.gov/41277399","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/12698047"},"language":"en","primary_location":{"id":"doi:10.1080/17568919.2025.2592533","doi":"https://doi.org/10.1080/17568919.2025.2592533","is_oa":false,"landing_page_url":"https://doi.org/10.1080/17568919.2025.2592533","pdf_url":null,"source":{"id":"https://openalex.org/S122867665","display_name":"Future Medicinal Chemistry","issn_l":"1756-8919","issn":["1756-8919","1756-8927"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320316","host_organization_name":"Future Science Ltd","host_organization_lineage":["https://openalex.org/P4310320316"],"host_organization_lineage_names":["Future Science Ltd"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12698047/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085545567","display_name":"Feyzi Sinan Tokal\u0131","orcid":"https://orcid.org/0000-0001-5532-8802","observed_orcids":["https://orcid.org/0000-0001-5532-8802"]},"institutions":[{"id":"https://openalex.org/I135987583","display_name":"Kafkas University","ror":"https://ror.org/04v302n28","country_code":"TR","type":"education","lineage":["https://openalex.org/I135987583"]}],"countries":["TR"],"is_corresponding":true,"raw_author_name":"Feyzi Sinan Tokali","raw_affiliation_strings":["Kafkas University"],"raw_orcid":"https://orcid.org/0000-0001-5532-8802","affiliations":[{"raw_affiliation_string":"Kafkas University","institution_ids":["https://openalex.org/I135987583"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015437021","display_name":"Halil \u015eenol","orcid":"https://orcid.org/0000-0002-8333-035X","observed_orcids":["https://orcid.org/0000-0002-8333-035X"]},"institutions":[{"id":"https://openalex.org/I3125175737","display_name":"Bezmi\u00e2lem Vak\u0131f \u00dcniversitesi","ror":"https://ror.org/04z60tq39","country_code":"TR","type":"education","lineage":["https://openalex.org/I3125175737"]}],"countries":["TR"],"is_corresponding":true,"raw_author_name":"Halil \u015eenol","raw_affiliation_strings":["Bezmialem Vakif University"],"raw_orcid":"https://orcid.org/0000-0002-8333-035X","affiliations":[{"raw_affiliation_string":"Bezmialem Vakif University","institution_ids":["https://openalex.org/I3125175737"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072606003","display_name":"\u015eeyma Ate\u015fo\u011flu","orcid":"https://orcid.org/0000-0001-7540-1456","observed_orcids":["https://orcid.org/0000-0001-7540-1456"]},"institutions":[{"id":"https://openalex.org/I3125175737","display_name":"Bezmi\u00e2lem Vak\u0131f \u00dcniversitesi","ror":"https://ror.org/04z60tq39","country_code":"TR","type":"education","lineage":["https://openalex.org/I3125175737"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"\u015eeyma Ate\u015fo\u011flu","raw_affiliation_strings":["Bezmialem Vakif University"],"raw_orcid":"https://orcid.org/0000-0001-7540-1456","affiliations":[{"raw_affiliation_string":"Bezmialem Vakif University","institution_ids":["https://openalex.org/I3125175737"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Pelin Tokal\u0131","orcid":"https://orcid.org/0000-0002-5553-9543","observed_orcids":["https://orcid.org/0000-0002-5553-9543"]},"institutions":[{"id":"https://openalex.org/I135987583","display_name":"Kafkas University","ror":"https://ror.org/04v302n28","country_code":"TR","type":"education","lineage":["https://openalex.org/I135987583"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Pelin Tokal\u0131","raw_affiliation_strings":["Kafkas University"],"raw_orcid":"https://orcid.org/0000-0002-5553-9543","affiliations":[{"raw_affiliation_string":"Kafkas University","institution_ids":["https://openalex.org/I135987583"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080853934","display_name":"Fahri Akba\u015f","orcid":"https://orcid.org/0000-0002-3837-250X","observed_orcids":["https://orcid.org/0000-0002-3837-250X"]},"institutions":[{"id":"https://openalex.org/I3125175737","display_name":"Bezmi\u00e2lem Vak\u0131f \u00dcniversitesi","ror":"https://ror.org/04z60tq39","country_code":"TR","type":"education","lineage":["https://openalex.org/I3125175737"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Fahri Akba\u015f","raw_affiliation_strings":["Bezmialem Vakif University"],"raw_orcid":"https://orcid.org/0000-0002-3837-250X","affiliations":[{"raw_affiliation_string":"Bezmialem Vakif University","institution_ids":["https://openalex.org/I3125175737"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5015437021","https://openalex.org/A5085545567"],"corresponding_institution_ids":["https://openalex.org/I135987583","https://openalex.org/I3125175737"],"apc_list":null,"apc_paid":null,"fwci":1.672,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.83470676,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"17","issue":"24","first_page":"2975","last_page":"2986"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/thiosemicarbazones","display_name":"thiosemicarbazones","score":0.9520000219345093},{"id":"https://openalex.org/keywords/thiazolidin-4-ones","display_name":"thiazolidin-4-ones","score":0.953000009059906},{"id":"https://openalex.org/keywords/androgen-receptor","display_name":"androgen receptor","score":0.8849999904632568},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.949999988079071},{"id":"https://openalex.org/keywords/pc-3-cells","display_name":"PC-3 cells","score":0.968999981880188},{"id":"https://openalex.org/keywords/selective-androgen-receptor-modulators","display_name":"selective androgen receptor modulators","score":0.8159999847412109},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.824999988079071},{"id":"https://openalex.org/keywords/cytotoxicity","display_name":"cytotoxicity","score":0.9129999876022339},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8889999985694885},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.7789999842643738},{"id":"https://openalex.org/keywords/mm-gbsa-binding-affinity","display_name":"MM-GBSA binding affinity","score":0.8899999856948853},{"id":"https://openalex.org/keywords/molecular-dynamics-simulation","display_name":"molecular dynamics simulation","score":0.7419999837875366}],"concepts":[{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.6808000206947327},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6294999718666077},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.5784000158309937},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.39890000224113464},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.38929998874664307},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.38440001010894775},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.36250001192092896},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.35910001397132874},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.3571999967098236},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3443000018596649},{"id":"https://openalex.org/C2780557392","wikidata":"https://www.wikidata.org/wiki/Q523796","display_name":"Linker","level":2,"score":0.33009999990463257},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.3140999972820282},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3100000023841858},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.3003999888896942},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.29260000586509705},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.28679999709129333},{"id":"https://openalex.org/C193042331","wikidata":"https://www.wikidata.org/wiki/Q1772003","display_name":"Structure\u2013activity relationship","level":3,"score":0.2854999899864197},{"id":"https://openalex.org/C2777911890","wikidata":"https://www.wikidata.org/wiki/Q62614","display_name":"Androgen","level":3,"score":0.28200000524520874},{"id":"https://openalex.org/C174510640","wikidata":"https://www.wikidata.org/wiki/Q489618","display_name":"HEK 293 cells","level":3,"score":0.2816999852657318},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.27880001068115234},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.2678000032901764},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.26579999923706055},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.2587999999523163},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.2515000104904175}],"mesh":[{"descriptor_ui":"D000078722","descriptor_name":"PC-3 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011944","descriptor_name":"Receptors, Androgen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011944","descriptor_name":"Receptors, Androgen","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013882","descriptor_name":"Thiosemicarbazones","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D013882","descriptor_name":"Thiosemicarbazones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013882","descriptor_name":"Thiosemicarbazones","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D053778","descriptor_name":"Thiazolidines","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D053778","descriptor_name":"Thiazolidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D053778","descriptor_name":"Thiazolidines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D056004","descriptor_name":"Molecular Dynamics Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061307","descriptor_name":"Human Umbilical Vein Endothelial Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D062105","descriptor_name":"Molecular Docking Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1080/17568919.2025.2592533","doi":"https://doi.org/10.1080/17568919.2025.2592533","is_oa":false,"landing_page_url":"https://doi.org/10.1080/17568919.2025.2592533","pdf_url":null,"source":{"id":"https://openalex.org/S122867665","display_name":"Future Medicinal Chemistry","issn_l":"1756-8919","issn":["1756-8919","1756-8927"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320316","host_organization_name":"Future Science Ltd","host_organization_lineage":["https://openalex.org/P4310320316"],"host_organization_lineage_names":["Future Science Ltd"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:41277399","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/41277399","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future medicinal chemistry","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:12698047","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12698047/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Med Chem","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:12698047","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC12698047/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Med Chem","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8560000061988831,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":44,"referenced_works":["https://openalex.org/W2176106583","https://openalex.org/W2808522316","https://openalex.org/W2962720586","https://openalex.org/W2979794109","https://openalex.org/W2986154842","https://openalex.org/W3004684853","https://openalex.org/W3038827218","https://openalex.org/W3080127776","https://openalex.org/W3096257697","https://openalex.org/W3110087536","https://openalex.org/W3118886469","https://openalex.org/W3128646645","https://openalex.org/W3151633358","https://openalex.org/W3204460556","https://openalex.org/W3216591159","https://openalex.org/W4220791353","https://openalex.org/W4283451354","https://openalex.org/W4310731088","https://openalex.org/W4313892082","https://openalex.org/W4319773506","https://openalex.org/W4362577193","https://openalex.org/W4377094265","https://openalex.org/W4385705355","https://openalex.org/W4390231515","https://openalex.org/W4391219513","https://openalex.org/W4392402080","https://openalex.org/W4396902557","https://openalex.org/W4399094862","https://openalex.org/W4399662983","https://openalex.org/W4401264325","https://openalex.org/W4401350589","https://openalex.org/W4401671077","https://openalex.org/W4402700991","https://openalex.org/W4404212995","https://openalex.org/W4405945150","https://openalex.org/W4406250757","https://openalex.org/W4408726773","https://openalex.org/W4409506351","https://openalex.org/W4409745096","https://openalex.org/W4410484078","https://openalex.org/W4411919011","https://openalex.org/W4412157839","https://openalex.org/W4412185836","https://openalex.org/W4412977713"],"related_works":["https://openalex.org/W4412157839","https://openalex.org/W7221961344","https://openalex.org/W2663516583","https://openalex.org/W7171509207","https://openalex.org/W4393275445","https://openalex.org/W4400696546","https://openalex.org/W4411049049","https://openalex.org/W7124170400","https://openalex.org/W4412454737","https://openalex.org/W4400406520"],"abstract_inverted_index":{"Aim":[0],"To":[1],"design,":[2],"synthesize,":[3],"and":[4,10,22,33,47,50,63,79,103,123,133,145,161,169,183,190,196,216],"evaluate":[5,100],"a":[6],"series":[7],"of":[8,39,105],"thiosemicarbazone":[9,31],"thiazolidin-4-one":[11],"hybrids":[12],"bearing":[13],"arylsulfonate":[14,185],"groups":[15],"as":[16],"potential":[17],"androgen":[18,90,209],"receptor-targeted":[19,210],"anticancer":[20,211],"agents.Materials":[21],"methods":[23],"The":[24,37,192],"compounds":[25,41],"were":[26,42,82,97],"synthesized":[27],"via":[28],"sequential":[29],"sulfonylation,":[30],"formation,":[32],"cyclization":[34,182],"to":[35,84,99],"thiazolidin-4-ones.":[36],"structures":[38],"the":[40,72,89,101,106,153,166],"characterized":[43],"using":[44,71],"NMR":[45],"(1H":[46],"13C),":[48],"FTIR,":[49],"HRMS":[51],"spectroscopic":[52],"techniques.":[53],"In":[54],"vitro":[55],"cytotoxicity":[56,118],"was":[57],"assessed":[58],"against":[59],"prostate":[60],"cancer":[61],"(PC3)":[62],"human":[64],"umbilical":[65],"vein":[66],"endothelial":[67],"cell":[68],"lines":[69],"(HUVEC)":[70],"MTT":[73],"(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium":[74],"bromide)":[75],"assay.":[76],"Molecular":[77,92],"docking":[78,154],"MM-GBSA":[80,134],"calculations":[81],"performed":[83],"predict":[85],"binding":[86,170],"affinities":[87],"toward":[88],"receptor.":[91],"dynamics":[93,104],"simulations":[94,148],"(250":[95],"ns)":[96],"conducted":[98],"stability":[102,168],"ligand":[107],"\u2013":[108],"protein":[109],"complexes.Results":[110],"Thiazolidin-4-one":[111],"derivatives,":[112],"particularly":[113,203],"compound":[114,204],"9,":[115,205],"exhibited":[116],"potent":[117],"(IC50":[119],"=":[120,127],"6.35":[121],"\u00b5M)":[122],"high":[124],"selectivity":[125],"(SI":[126],"6.05)":[128],"over":[129],"HUVEC":[130],"cells.":[131],"Docking":[132],"analyses":[135],"revealed":[136],"strong":[137],"interactions":[138],"with":[139],"key":[140],"residues":[141],"His-874,":[142],"Met-742,":[143],"Trp-741,":[144],"Arg-752.":[146],"MD":[147],"confirmed":[149],"minimal":[150],"deviation":[151],"from":[152],"pose":[155],"(0.75":[156],"\u00c5),":[157],"low":[158],"RMSD/RMSF":[159],"values,":[160],"persistent":[162],"hydrogen-bonding":[163],"networks,":[164],"supporting":[165],"structural":[167],"affinity":[171],"observed":[172],"in":[173],"vitro.":[174],"Structure\u2013activity":[175],"relationship":[176],"(SAR)":[177],"analysis":[178],"indicated":[179],"that":[180,200],"scaffold":[181],"appropriate":[184],"substitution":[186],"enhance":[187],"receptor":[188],"engagement":[189],"selectivity.Conclusions":[191],"combined":[193],"synthetic,":[194],"computational,":[195],"biological":[197],"results":[198],"demonstrate":[199],"thiazolidin-4-one-based":[201],"hybrids,":[202],"are":[206],"promising":[207],"selective":[208],"agents,":[212],"warranting":[213],"further":[214],"optimization":[215],"development.":[217]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2025-11-25T00:00:00"}